Kimball AB - Search Results

1

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.

Jemec GBE, Okun MM, Forman SB, Gulliver WPF, Prens EP, Mrowietz U, Armstrong AW, Geng Z, Gu Y, Williams DA, Teixeira HD, Kimball AB. Jemec GBE, et al. Among authors: kimball ab. Br J Dermatol. 2019 Nov;181(5):967-975. doi: 10.1111/bjd.17919. Epub 2019 Aug 14. Br J Dermatol. 2019. PMID: 30916379 Free PMC article. Clinical Trial.

2

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG, Strober BE, Kaul M, Gu Y, Okun M, Papp K. Menter A, et al. Among authors: kimball ab. J Am Acad Dermatol. 2008 Jan;58(1):106-15. doi: 10.1016/j.jaad.2007.09.010. Epub 2007 Oct 23. J Am Acad Dermatol. 2008. PMID: 17936411 Clinical Trial.

3

Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.

Revicki DA, Willian MK, Menter A, Gordon KB, Kimball AB, Leonardi CL, Langley RG, Kimel M, Okun M. Revicki DA, et al. Among authors: kimball ab. J Dermatolog Treat. 2007;18(6):341-50. doi: 10.1080/09546630701646172. J Dermatolog Treat. 2007. PMID: 18058494 Clinical Trial.

4

Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial.

Kimball AB, Gordon KB, Langley RG, Menter A, Chartash EK, Valdes J; ABT-874 Psoriasis Study Investigators. Kimball AB, et al. Arch Dermatol. 2008 Feb;144(2):200-7. doi: 10.1001/archdermatol.2007.63. Arch Dermatol. 2008. PMID: 18283176 Clinical Trial.

5

Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trial.

Kimball AB, Bensimon AG, Guerin A, Yu AP, Wu EQ, Okun MM, Bao Y, Gupta SR, Mulani PM. Kimball AB, et al. Am J Clin Dermatol. 2011 Feb 1;12(1):51-62. doi: 10.2165/11530640-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21110526 Clinical Trial.

6

Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis.

Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, You Y, Hsu MC, Yeilding N, Rader DJ, Mehta NN. Kimball AB, et al. J Am Acad Dermatol. 2012 Jul;67(1):76-85. doi: 10.1016/j.jaad.2011.06.035. Epub 2011 Oct 22. J Am Acad Dermatol. 2012. PMID: 22018756

7

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years.

Kimball AB, Gordon KB, Fakharzadeh S, Yeilding N, Szapary PO, Schenkel B, Guzzo C, Li S, Papp KA. Kimball AB, et al. Br J Dermatol. 2012 Apr;166(4):861-72. doi: 10.1111/j.1365-2133.2012.10901.x. Br J Dermatol. 2012. PMID: 22356258 Clinical Trial.

8

Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.

Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee HH, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec GB. Kimball AB, et al. Ann Intern Med. 2012 Dec 18;157(12):846-55. doi: 10.7326/0003-4819-157-12-201212180-00004. Ann Intern Med. 2012. PMID: 23247938 Clinical Trial.

9

Treatment of moderate to severe hidradenitis suppurativa.

Kimball AB, Gu Y, Okun M. Kimball AB, et al. Ann Intern Med. 2013 Jul 2;159(1):72-3. doi: 10.7326/0003-4819-159-1-201307020-00016. Ann Intern Med. 2013. PMID: 23817710 No abstract available.

10

A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris.

Palli MB, Reyes-Habito CM, Lima XT, Kimball AB. Palli MB, et al. Among authors: kimball ab. J Drugs Dermatol. 2013 Jun 1;12(6):633-7. J Drugs Dermatol. 2013. PMID: 23839178 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page